Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease.
Alzforum,
Chen D, Chen Q, Qin X, Tong P, Peng L, Zhang T, Xia C. Front Aging Neurosci. 2023;15:1209863.